Lipitor
Subjective Cognitive Decline
University of Texas Southwestern Medical CenterPhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Subjective Cognitive Decline cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
AMLODIPINE Rong Zhang | Phase 2/3 | BB |
Losartan Rong Zhang | Phase 2/3 | BB |
NEPENTHE Chang Gung Memorial Hospital | N/A | D |
Sra-333 Shaanxi Hospital of Traditional Chinese Medicine | N/A | D |
METAMIZOLE Chang Gung Memorial Hospital | N/A | D |
DEXKETOPROFEN Chang Gung Memorial Hospital | N/A | D |
Same molecule, other indications
Lipitor is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →